Editorials

• Vascular Age Versus Cardiovascular Risk: Clarifying Concepts

  José I. Cuende

  Rev Esp Cardiol. 2016;69:243-6

• Iron and Exercise in Heart Failure: How to Assess Relevant Changes?

  Nicole Ebner, Stephan von Haehling

  Rev Esp Cardiol. 2016;69:237-8

• Comments on the 2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension

  P. Escribano Subias

  Rev Esp Cardiol. 2016;69:102-8

• Comments on the 2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

  I. Fernández-Lozano

  Rev Esp Cardiol. 2016;69:94-101

• Bioresorbable Scaffolds and Plaque Regression: Raising the Bar in the Promised Land of Vascular Restoration Therapy

  Davide Capodanno

  Rev Esp Cardiol. 2016;69:91-3

• Long-term Cardiovascular Risk After Acute Coronary Syndrome, An Ongoing Challenge

  Héctor Bueno, Roberto Martín Asenjo

  Rev Esp Cardiol. 2016;69:1-2

• Transvenous Lead Extraction of Cardiac Implantable Electronic Devices: Who, When, How and Where?

  Ayman A. Hussein, Bruce L. Wilkoff

  Rev Esp Cardiol. 2016;69:3-6

• Comments on the ESC 2015 Guidelines for the Management of Infective Endocarditis

  A. San Román

  Rev Esp Cardiol. 2016;69:7-10

• Comments on the 2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation

  J. Barrabes

  Rev Esp Cardiol. 2015;68:1061-7

• Comments on the 2015 ESC Guidelines for the Diagnosis and Management of Pericardial Diseases. A Report by the Spanish Society of Cardiology Guidelines Committee Working Group

  J. Guindo

  Rev Esp Cardiol. 2015;68:1068-74

• Plasma Neprilysin Concentrations: A New Prognostic Marker in Heart Failure?

  A. Mark Richards

  Rev Esp Cardiol. 2015;68:1053-5

• Pulmonary Vein Stenosis After Ablation: The Difference Between Clinical Symptoms and Imaging Findings, and the Importance of Definitions in This Context

  Jesús Almendral, María Teresa Barrio-López

  Rev Esp Cardiol. 2015;68:1056-8

• What's New in Constrictive Pericarditis? A European Perspective

  Massimo Imazio, Fiorenzo Gaita

  Rev Esp Cardiol. 2015;68:1059-60

• Improving Quality of Cardiac Care: A Global Mandate

  Sidney C. Smith, Gregg C. Fonarow, Ileana L. Piña, Robert Suter, Louise Morgan, Kathryn Taubert, Eduardo Sanchez, Elliott Antman

  Rev Esp Cardiol. 2015;68:924-7

• Slowing Sinus Tachycardia in Heart Transplant Recipients: Is It Time?

  Kambiz Ghafourian, Jon A. Kobashigawa

  Rev Esp Cardiol. 2015;68:921-3

• Microvascular Obstruction: The Bane of Myocardial Reperfusion

  Heerajnarain Bulluck, Derek J. Hausenloy

  Rev Esp Cardiol. 2015;68:919-20

• Introduction of Innovations in Heart Disease in Spain: InnovaSEC

  Laura Sampietro-Colom, Josep Brugada-Terradellas, José R. González-Juanatey

  Rev Esp Cardiol. 2015;68:834-7

• Diabetes and Screening for Coronary Heart Disease: Where Should We Focus our Efforts?

  Jesús María de la Hera, José Manuel García-Ruiz, Elías Delgado

  Rev Esp Cardiol. 2015;68:830-3

• Duration of Dual Antiplatelet Therapy After Drug-eluting Stents Implantation: The Jury Is Still Out

  Stefanie Schulz-Schüpke, Adnan Kastrati

  Rev Esp Cardiol. 2015;68:827-9

• Recreating the Sinus Node by Somatic Reprogramming: A Dream Come True?

  Eugenio Cingolani, Eduardo Marbán

  Rev Esp Cardiol. 2015;68:743-5